BAQSIMI
Drug
Lilly USA, LLC
Total Payments
$1.2M
Transactions
34,871
Doctors
9,033
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $7,409 | 253 | 194 |
| 2023 | $97,283 | 5,544 | 2,667 |
| 2022 | $151,757 | 8,997 | 4,036 |
| 2021 | $397,688 | 9,938 | 4,178 |
| 2020 | $388,836 | 6,032 | 2,279 |
| 2019 | $192,436 | 4,107 | 1,843 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $646,850 | 728 | 52.4% |
| Food and Beverage | $569,077 | 33,999 | 46.1% |
| Consulting Fee | $13,425 | 11 | 1.1% |
| Travel and Lodging | $6,057 | 133 | 0.5% |
Top Doctors Receiving Payments for BAQSIMI — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , DO | Endocrinology, Diabetes & Metabolism | Westerville, OH | $10,076 | 20 |
| , MD | Endocrinology, Diabetes & Metabolism | Raleigh, NC | $8,434 | 17 |
| , M.D.L | Endocrinology, Diabetes & Metabolism | Columbia, MD | $7,145 | 11 |
| , APRN | Nurse Practitioner | New Haven, CT | $7,100 | 17 |
| , M.D., M.P.H | Family Medicine | New Braunfels, TX | $6,599 | 15 |
| , APRN | Nurse Practitioner | Topeka, KS | $5,059 | 15 |
| , DO | Internal Medicine | Kalamazoo, MI | $4,794 | 6 |
| , N.P | Nurse Practitioner | Ogden, UT | $4,282 | 20 |
| , M.D | Endocrinology, Diabetes & Metabolism | Saint Louis, MO | $4,062 | 9 |
| , M.D | Family Medicine | San Antonio, TX | $3,498 | 12 |
| , MD | Endocrinology, Diabetes & Metabolism | Terre Haute, IN | $3,416 | 27 |
| , MD | Endocrinology, Diabetes & Metabolism | Charlotte, NC | $3,088 | 5 |
| , M.D | Internal Medicine | Greenvale, NY | $1,788 | 1 |
| , MD | Family Medicine | Edmond, OK | $1,734 | 5 |
| , MD | Endocrinology, Diabetes & Metabolism | Beaumont, TX | $1,625 | 2 |
| , M.D | Specialist | Encino, CA | $1,544 | 1 |
| , M.D | Endocrinology, Diabetes & Metabolism | San Diego, CA | $1,210 | 2 |
| , MSN,APRN-BC,BC-AMD | Registered Nurse | Detroit, MI | $1,056 | 1 |
| , MD | Endocrinology, Diabetes & Metabolism | Branford, CT | $797.70 | 48 |
| , MD | Endocrinology, Diabetes & Metabolism | Pittsburgh, PA | $782.81 | 43 |
| , MD | Endocrinology, Diabetes & Metabolism | South Miami, FL | $781.60 | 38 |
| , M.D | Endocrinology, Diabetes & Metabolism | Rockville, MD | $769.43 | 33 |
| , MD | Endocrinology, Diabetes & Metabolism | Birmingham, AL | $674.19 | 32 |
| , M.D | Endocrinology, Diabetes & Metabolism | Long Beach, CA | $670.06 | 29 |
| , M.D | Endocrinology, Diabetes & Metabolism | Miami, FL | $669.07 | 31 |
Ad
Manufacturing Companies
- Lilly USA, LLC $1.2M
- Amphastar Pharmaceuticals, Inc. $11,727
- Eli Lilly and Company $3,900
- Eli Lilly Export S.A. Puerto Rico Branch $20.00
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 9,033
- Transactions 34,871
About BAQSIMI
BAQSIMI is a drug associated with $1.2M in payments to 9,033 healthcare providers, recorded across 34,871 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2019 to 2024. In 2024, $7,409 was paid across 253 transactions to 194 doctors.
The most common payment nature for BAQSIMI is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($646,850, 52.4% of total).